Analyst Ratings for Champions Oncology (CSBR)
CSBR Rating Summary
CSBR Price Target Summary
- Highest: $10.00 (Craig-Hallum)
- Lowest: $7.50 (Roth/MKM)
- Average: $8.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.75 (+76.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$8.75 (+76.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/16/2023 | Benchmark | Robert Wasserman | Downgrade | Hold (Buy) |
N/A (N/A) |
4.10 (4.97) |
21.22% | Details |
| 9/20/2019 | Roth/MKM » Updated 9/22/2023 |
Scott Henry | New Coverage | Buy (N/A) |
7.50 (9.00) |
6.08 (4.97) |
-18.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
